XML 39 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Summary of Combined Stock Option Activity under 2021 Plan

The following table summarizes stock option activity under the 2018 Plan and 2021 Plan for the three months ended March 31, 2022:

 

 

 

Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term
(years)

 

 

Aggregate Intrinsic
Value

 

Outstanding at December 31, 2021

 

 

4,232,991

 

 

$

7.43

 

 

 

8.66

 

 

$

40,437

 

Granted

 

 

98,897

 

 

 

18.56

 

 

 

 

 

 

 

Exercised

 

 

(5,593

)

 

 

2.97

 

 

 

 

 

 

 

Cancelled/Forfeited

 

 

(43,433

)

 

 

12.18

 

 

 

 

 

 

 

Outstanding at March 31, 2022

 

 

4,282,862

 

 

$

7.64

 

 

 

8.52

 

 

$

61,492

 

Exercisable at March 31, 2022

 

 

1,341,363

 

 

$

4.10

 

 

 

6.82

 

 

$

24,015

 

Schedule of Fair Value of Stock Options, Valuation Assumptions

The fair value of the stock options issued for the three months ended March 31, 2022 and 2021 was measured with the following weighted-average assumptions:

 

 

 

Three Months Ended
March 31,

 

 

 

2022

 

 

2021

 

Risk-free interest rate, %

 

 

1.56

%

 

 

1.02

%

Expected term

 

 

6.01

 

 

 

6.08

 

Expected volatility of the underlying stock, %

 

 

73.02

%

 

 

73.16

%

Expected dividend rate, %

 

 

%

 

 

%

Schedule of Nonvested Restricted Stock Units Activity

Restricted Stock Units

 

The Company has granted restricted stock units with service vesting based conditions. Unvested shares of restricted common stock may not be sold or transferred by the holder. They are legally issued and outstanding. These restrictions lapse accordingly to the time-based vesting of each award.

 

A summary of the restricted stock units activity during the three months ended March 31, 2022 is as follows:

 

 

 

Restricted Stock Units

 

 

Weighted-
Average
Grant Date Fair Value

 

Unvested at December 31, 2021

 

 

231,920

 

 

$

14.00

 

Granted

 

 

 

 

 

 

Forfeited

 

 

(4,066

)

 

 

14.00

 

Unvested at March 31, 2022

 

 

227,854

 

 

$

14.00

 

Summary of Stock-Based Compensation Expense

The Company recorded stock-based compensation expense as follows (in thousands):

 

 

 

Three Months Ended
March 31,

 

 

 

2022

 

 

2021

 

Research and development

 

$

555

 

 

$

44

 

General and administrative

 

 

1,039

 

 

 

141

 

Total

 

$

1,594

 

 

$

185